🇺🇸 FDA
Pipeline program

Sinovac Low-dosage PCV24

PRO-PCV24-1004

Phase 2 mab completed

Quick answer

Sinovac Low-dosage PCV24 for Pneumococcal Infectious Disease is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Pneumococcal Infectious Disease
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials